Skip to Content

Dibucaine topical Pregnancy and Breastfeeding Warnings

Dibucaine topical is also known as: Nupercainal, Rectacaine

Dibucaine topical Pregnancy Warnings

Dibucaine topical has been assigned to pregnancy category C by the FDA. Animal study data have not been reported. There are no controlled data in human pregnancy. Caution is recommended when dibucaine topical is administered during pregnancy.

Dibucaine topical Breastfeeding Warnings

There are no data on the excretion of dibucaine into human milk. Caution is recommended when dibucaine topical is administered to a nursing mother.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.